Clinical Trial Update: Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting

View source ↗

Summary

A clinical trial led by Peking Union Medical College Hospital is currently recruiting to predict drug response in gastric cancer using 3D bioprinting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: STOMACH NEOPLASM | Status: RECRUITING